InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (7 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
7
T+90 hit rate
47%
T+90 mean return
+4.3%
Across 15 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Brown Ryan Edward, Vice-Président Senior, Conseiller Général. Director active across 1 company, notably Sarepta Therapeutics, Inc.. Aggregated, 22 reports have been published. Split: 0 buy · 7 sells. Total volume traded: €5.9m. Activity tracked since 1 June 2021. The latest transaction was filed on 25 June 2024 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations22 total
2,352 shares@ US$164.644.3% of flowCommon StockSEC:0000950170-24-077522:1
23,500 shares@ US$62.7716.6% of flowCommon StockSEC:0000950170-24-077522:2
7,644 shares@ US$158.0713.6% of flowCommon StockSEC:0000950170-24-077522:3
2,200 shares@ US$159.143.9% of flowCommon StockSEC:0000950170-24-077522:4
975 shares@ US$160.311.8% of flowCommon StockSEC:0000950170-24-077522:5
4,168 shares@ US$161.827.6% of flowCommon StockSEC:0000950170-24-077522:6
17,581 shares@ US$162.6532.1% of flowCommon StockSEC:0000950170-24-077522:7
3,840 shares@ US$163.537.1% of flowCommon StockSEC:0000950170-24-077522:8
6,250 sharesCommon StockSEC:0000950170-24-077522:0
2,549 shares@ US$164.524.7% of flowCommon StockSEC:0000950170-24-077522:9
506 shares@ US$120.490.7% of flowCommon StockSEC:0000950170-24-029530:0
1,734 shares@ US$125.322.4% of flowCommon StockSEC:0000950170-24-027495:0
269 shares@ US$126.190.4% of flowCommon StockSEC:0000950170-24-026609:0
89 shares@ US$123.600.1% of flowCommon StockSEC:0001209191-23-034676:0
635 shares@ US$153.191.1% of flowCommon StockSEC:0001209191-23-018019:0
1,154 shares@ US$157.212.1% of flowCommon StockSEC:0001209191-23-017400:0
196 shares@ US$147.570.3% of flowCommon StockSEC:0001209191-23-016057:0
54 shares@ US$72.670.0002% mcap3.5% of flowCommon StockSEC:0001209191-22-034380:0
1,136 shares@ US$79.200.0036% mcap77.2% of flowCommon StockSEC:0001209191-22-017346:0
184 shares@ US$75.050.0005% mcap11.7% of flowCommon StockSEC:0001209191-22-014407:0
64 shares@ US$76.010.0002% mcap3.8% of flowCommon StockSEC:0001209191-21-037727:0
64 shares@ US$76.010.0% of flowCommon StockSEC:0001209191-21-037727
22 of 22 declarations
About Brown Ryan Edward
Ryan Edward Brown serves as SVP, General Counsel at Sarepta Therapeutics, Inc. He oversees the legal affairs of the company, ensuring compliance with regulations and laws. His role is essential in protecting the interests of Sarepta Therapeutics, Inc. and supporting strategic decision-making. Brown is committed to promoting legal best practices within the organization.
